Drug Discovery Product Showcase
-
Parenteral Formulation Development
6/16/2025
Discover how this chemical structure enhances the solubility, stability, and bioavailability of small molecule drugs and complex biologics, making it an indispensable tool in pharmaceutical development.
-
Seamless International Supply Chain And 3pL Services In Strategic Locations
6/16/2025
Expand your pharmaceutical operations in Europe with strategically located facilities offering temperature-controlled storage, streamlined supply chain management, and expert import/export support.
-
Formulation Development: Science, Strategy, And Smarter Solutions
6/16/2025
Explore how to navigate the complexities of pharmaceutical formulation when development is a high-stakes, precision-driven science, especially for early-phase injectable drugs.
-
Services Designed To Take You From Molecule To Market
6/12/2025
Accelerate your biopharma journey with a comprehensive service portfolio designed to speed development, reduce costs, and minimize risk from molecule to market.
-
High-Performance UF Membrane For Precision Filtration
6/4/2025
Discover an easy-to-use, efficient solution for small-volume filtration that streamlines concentration and diafiltration, minimizes product loss, and supports diverse applications across life science research.
-
Precision Filtration With Unmatched Control And Seamless Validation
6/4/2025
Experience reliable, user-friendly buffer exchange and sample concentration with a system enhanced with precise pressure control, improved stirring, and durable components for effortless lab-scale filtration.
-
A Fast, Scalable, And Reliable Digital PCR System
5/13/2025
Detecting rare genetic variants in a sea of background noise is a major challenge in molecular biology. Discover a digital PCR system that offers precise, absolute quantification to transform how researchers tackle complex genetic detection.
-
Advancing Cell And Gene Therapy Development With Digital PCR
5/13/2025
Discover innovative tools and solutions designed to ensure safety, precision, and efficiency in cell and gene therapy development—empowering teams to accelerate breakthroughs from discovery to commercialization.
-
Prometheus Panta C: Precision That Powers Biopharma Breakthroughs
5/6/2025
Controlled by software designed to meet 21 CFR Part 11 regulatory standards, Prometheus Panta C facilitates data integrity through distinct user access groups, while Active Directory integration provides centralized user authentication. Features such as electronic signatures, electronic records, and comprehensive audit trails further strengthen regulatory alignment.
-
On- And Off-Target Gene Editing Assessment Services
2/21/2025
Patient safety is critical for regulatory success. SeQure Dx specializes in off-target analysis services to reduce risk and improve the safety profile of gene-edited cell and gene therapies. Our advanced assays ensure precise editing confirmation and thorough risk assessment across viral and non-viral editing platforms.